Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

September 04, 2025
Purdue Pharma Approved For $17.5M In Ch. 11 Bonus Plans

Bankrupt pharmaceutical company Purdue Pharma LP received approval from a New York judge Thursday to pay more than $17.5 million in employee bonuses, mirroring the bonus structures of the last few years since the company commenced its Chapter 11 case.
August 29, 2025
What's Happening In Bankruptcy Court This Coming Week

A New York bankruptcy court will consider letting Purdue Pharma collaborate with a nonprofit on a cancer drug. A Delaware bankruptcy judge is slated to hear Monster.com's bid to begin soliciting votes on a Chapter 11 plan. And another bankruptcy judge in Delaware will weigh whether to grant interim approval for the combined plan and disclosure of Heritage Coal's owner.
August 20, 2025
Purdue Asks Bankruptcy Court To OK Drug Trial Collaboration

Purdue Pharma LP asked a New York bankruptcy court to allow it to enter a clinical trial collaboration with a nonprofit, saying that doing so would allow Purdue to continue developing a potential treatment for a deadly brain cancer while restraining costs.
July 31, 2025
Purdue Government Group Gets OK To Hire Claims Admin

A New York bankruptcy judge Thursday gave an ad hoc governmental group permission to hire an administrator to handle claims in Purdue Pharma's $8 billion Chapter 11 plan, saying the administrator's services are needed.
July 01, 2025
Top Personal Injury, Med Mal News: 2025 Midyear Report

A U.S. Supreme Court ruling over whether personal injury claims can be brought under a RICO statute and a $7.4 billion settlement reached with the Sackler family and Purdue Pharma are among Law360's top personal injury and medical malpractice cases from the first six months of 2025.
June 23, 2025
23andMe Sale Nears Ruling, Tariff Policies Drive Bankruptcy

A Missouri bankruptcy judge said he will soon rule on the proposed $305 million sale of 23andMe to a nonprofit led by its co-founder. Meanwhile, shifting tariff policies under President Donald Trump have been blamed for recent bankruptcies, and experts at a conference in New York discussed the future of Chapter 11 and how a second Trump term could shape bankruptcy law.
June 20, 2025
2nd Purdue Plan Heading For Creditor Vote, Nov. Hearing

A New York bankruptcy judge Friday set OxyContin maker Purdue Pharma's second try at a bankruptcy plan on course for a November confirmation hearing, clearing the plan disclosure statement to be sent out for a creditor vote.
June 18, 2025
Purdue Pharma Seeks Vote On New $8B Ch. 11 Plan

Close to a year after the U.S. Supreme Court shot down an earlier version of its Chapter 11 plan, OxyContin maker Purdue Pharma was before a New York bankruptcy judge Wednesday to ask for permission to send its revised plan out for a creditor vote.
June 16, 2025
All 50 States Agree To Purdue Pharma's $7.4B Settlement

Attorneys general from 55 U.S. states and territories on Monday backed Purdue Pharma's $7.4 billion deal to settle opioid injury claims against the company and the Sackler family, almost a year after the U.S. Supreme Court threw out Purdue's previous plan to end litigation over its role in the opioid epidemic.
June 13, 2025
What's Happening In Bankruptcy Court This Coming Week

Vodka company Stoli Group and pharmaceutical giant Purdue are both headed to court to make the case for their bankruptcy plan disclosure statements, New Hampshire power plant operator Burgess BioPower will try to get its Chapter 11 plan confirmed, and trucking company Yellow Corp. is facing a bid to send it to liquidation.

← Previous
1
2
3
4
5
6
7
8
9
…
Next →